Sign In
Register
eISSN:2278-5299

International Journal of Latest Research in Science and Technology

DOI:10.29111/ijlrst   ISRA Impact Factor:3.35

A News Letter Sign UP!
INVESTIGATION AND CHARACTERIZATION OF THE ANTIPLATELET ACTIVITIES OF PHYSALIN B

Research Paper Open Access

International Journal of Latest Research in Science and Technology Vol.3 Issue 6, pp 114-120,Year 2014

INVESTIGATION AND CHARACTERIZATION OF THE ANTIPLATELET ACTIVITIES OF PHYSALIN B

Chia-Chun Hsu,Ping-Yen Liu, Lynn Farh,Wei-Kung Tseng, Kai-Chien Yang, Chau-Chung Wu,Fang-Rong Chang

Correspondence should be addressed to :

Received : 20 December 2014; Accepted : 26 December 2014 ; Published : 31 December 2014

Share
Download 125
View 177
Article No. 10433
Abstract

Physalin B is a steroidal triterpenoid whose effects on platelet functions are not clearly understood. This paper presents novel in vitro and ex vivo studies on the effects of physalin B on platelet activation and thrombosis formation. Peripheral blood mononuclear cells were cultured to obtain two types of endothelial progenitor cells from the same donors. MTT and cell adhesion assays were performed to evaluate cell viability and the adhesion of THP-1 cells to human umbilical vein endothelial cells (HUVECs), respectively. Biomarkers included prothrombin time (PT) and activated partial thromboplastin time (APTT). The experimental results indicated that physalin B can inhibit the activation of human platelets through an ex vivo interfering arachidonic acid pathway and can block the activation of P2Y12 receptors. Moreover, the antiplatelet function of physalin B does not affect plasma coagulation because both PT and APTT remain unchanged after treatment. Furthermore, physalin B at 80 μM can reduce the TNF-α-induced adhesion of monocytic leukocyte THP-1 cells to HUVECs in a cell adhesion assay. These results suggest that the antithrombotic activity of physalin B is attributed to its antiplatelet activation and antiinflammatory effects. To the best of our knowledge, this study is the first to report on the antiplatelet effect of secosteroidal physalin-type compounds.

Key Words   
Physalin B, platelet activation, anticoagulation

Copyright
References
  1. Angiolillo DJ, Bhatt DL, Gurbel PA, Jennings Advances in antiplatelet therapy: agents in clinical development. Am J Cardiol 2009;103:40A–51A.
  2. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005;115:3378–84.
  3. Langer HF, Gawaz M. Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 2008;99:480–6.
  4. May AE, Seizer P, Gawaz M. Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol 2008;28:s5–10.
  5. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964–7.
  6. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593–600.
  7. Roberts N, Jahangiri M, Xu Q. Progenitor cells in vascular disease. J Cell Mol Med 2005;9:583–91.
  8. Rumpold H, Wolf D, Koeck R, Gunsilius E. Endothelial progenitor cells: a source for therapeutic vasculogenesis? J Cell Mol Med 2004;8:509–18.
  9. Werner N, Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arterioscler Thromb Vasc Biol 2006;26:257–66.
  10. Soares MB, Bellintani MC, Ribeiro IM, Tomassini TC, Ribeiro dos Santos R. Inhibition of macrophage activation and lipopolysaccaride-induced death by seco-steroids purified from Physalis angulata Eur J Pharmacol 2003;459:107–12.
  11. Hsu CC, Wu YC, Farh L, Du YC, Tseng WK, Wu CC, et al. Physalin B from Physalis angulata triggers the NOXA-related apoptosis pathway of human melanoma A375 cells. Food Chem Toxicol 2012;50:619–24.
  12. Vandenberghe I, Creancier L, Vispe S, Annereau JP, Barret JM, Pouny I, et al. Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis. Biochem Pharmacol 2008;76:453–62.
  13. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 1995;2:493–506.
  14. Im SY, Han SJ, Ko HM, Choi JH, Chun SB, Lee DG, et al. Involvement of nuclear factor-kappa B in platelet-activating factor-mediated tumor necrosis factor-alpha expression. Eur J Immunol 1997;27:2800–4.
  15. Castro DP, Figueiredo MB, Genta FA, Ribeiro IM, Tomassini TC, Azambuja P, et al. Physalin B inhibits Rhodnius prolixus hemocyte phagocytosis and microaggregation by the activation of endogenous PAF-acetyl hydrolase activities. J Insect Physiol 2009;55:532–7.
  16. Soares MB, Brustolim D, Santos LA, Bellintani MC, Paiva FP, Ribeiro YM, et al. Physalins B, F and G, seco-steroids purified from Physalis angulata L, inhibit lymphocyte function and allogeneic transplant rejection. Int Immunopharmacol 2006;6:408–14.
  17. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999;340:115–26.
  18. Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:234S–64S.
  19. Scarborough RM, Kleiman NS, Phillips DR. Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use? Circulation 1999;100:437–44.
  20. Hu Y, Davison F, Zhang Z, Xu Q. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 2003;108:3122–7.
  21. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430–6.
  22. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004;24:288–93.
  23. Sieveking DP, Buckle A, Celermajer DS, Ng MK. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 2008;51:660–8.
  24. Wittchen ES. Endothelial signaling in paracellular and transcellular leukocyte transmigration. Front Biosci 2009;14:2522–45.
  25. Vieira AT, Pinho V, Lepsch LB, Scavone C, Ribeiro IM, Tomassini T, et al. Mechanisms of the anti-inflammatory effects of the natural secosteroids physalins in a model of intestinal ischaemia and reperfusion injury. Br J Pharmacol 2005;146:244–51.
To cite this article

Chia-Chun Hsu,Ping-Yen Liu, Lynn Farh,Wei-Kung Tseng, Kai-Chien Yang, Chau-Chung Wu,Fang-Rong Chang , " Investigation And Characterization Of The Antiplatelet Activities Of Physalin B ", International Journal of Latest Research in Science and Technology . Vol. 3, Issue 6, pp 114-120 , 2014

Responsive image

MNK Publication was founded in 2012 to upholder revolutionary ideas that would advance the research and practice of business and management. Today, we comply with to advance fresh thinking in latest scientific fields where we think we can make a real difference and growth now also including medical and social care, education,management and engineering.

Responsive image

We offers several opportunities for partnership and tie-up with individual, corporate and organizational level. We are working on the open access platform. Editors, authors, readers, librarians and conference organizer can work together. We are giving open opportunities to all. Our team is always willing to work and collaborate to promote open access publication.

Responsive image

Our Journals provide one of the strongest International open access platform for research communities. Our conference proceeding services provide conference organizers a privileged platform for publishing extended conference papers as journal publications. It is deliberated to disseminate scientific research and to establish long term International collaborations and partnerships with academic communities and conference organizers.